 
 
GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| Compound class: 
                                                            Synthetic organic
                                 
                                    
                                        Comment: Benapenem is a carbapenem (β-lactam) with broad-spectrum antibacterial activity [2]. It has advanced to clinical evaluation as an intravenous treatment for urinary tract infections.
                                    
                                 | 
 | |||||||||||||||||||||||||||||||||||
| No information available. | 
| Summary of Clinical Use  | 
| Benapenem, like ertapenem, has a longer serum half-life (~7 h) than other prescribed carbapenems making it suitable for once-daily administration [2]. Benapenem has progressed to Phase 2/3 evaluation as a treatment for complicated urinary tract infection (cUTI) and acute pyelonephritis (NCT04505683, recruitment completed). | 
| Clinical Trials | |||||
| Clinical Trial ID | Title | Type | Source | Comment | References | 
| NCT04505683 | A Study to Assess Efficacy and Safety Intravenous Benapenem in Patients With Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis (AP) | Phase 2/Phase 3 Interventional | Sihuan Pharmaceutical Holdings Group Ltd. | ||